EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC 3.0

Severe Cytokine Release Syndrome and Hemophagocytic Lymphohistiocytosis (HLH)-Like Syndrome Following Administration of Combined Brentuximab Vedotin and Nivolumab for Recurrent Classical Hodgkin Lymphoma: A Case Report

Osama Mosalem iD, Tanmayi Pai iD, Mohammed Alqawasma, Marwan Shaikh, K David Li, Muhamad Alhaj Moustafa iD

Journal of Blood Medicine · 2024-01 · Volume 15 · 29-34

DOI: 10.2147/jbm.s444004 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Journal of Blood Medicine, 2024-01. Verfasst von Osama Mosalem und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology/Oncology, Mayo Clinic, Jacksonville, FL, USA. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

CRSantibody drug conjugateimmune-related adverse eventimmunotherapy

Autor:innen und Institutionen

  • Department of Hematology/Oncology, Mayo Clinic, Jacksonville, FL, USA.
  • Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Jacksonville, FL, USA.
  • Department of Laboratory Medicine and Pathology, Mayo Clinic, Jacksonville, FL, USA.

ORCID-Profile: Osama Mosalem, Tanmayi Pai, Muhamad Alhaj Moustafa

Zitieren

APA

Mosalem, O., Pai, T., Alqawasma, M., Shaikh, M., Li, K. D., & Alhaj Moustafa, M. (2024). Severe Cytokine Release Syndrome and Hemophagocytic Lymphohistiocytosis (HLH)-Like Syndrome Following Administration of Combined Brentuximab Vedotin and Nivolumab for Recurrent Classical Hodgkin Lymphoma: A Case Report. Journal of Blood Medicine, Volume 15, 29-34. https://doi.org/10.2147/jbm.s444004

Vancouver

Mosalem O, Pai T, Alqawasma M, Shaikh M, Li KD, Alhaj Moustafa M. Severe Cytokine Release Syndrome and Hemophagocytic Lymphohistiocytosis (HLH)-Like Syndrome Following Administration of Combined Brentuximab Vedotin and Nivolumab for Recurrent Classical Hodgkin Lymphoma: A Case Report. Journal of Blood Medicine. 2024;Volume 15:29-34. doi:10.2147/jbm.s444004

BibTeX
@article{Mosalem2024,
  author = {Mosalem, Osama and Pai, Tanmayi and Alqawasma, Mohammed and Shaikh, Marwan and Li, K David and Alhaj Moustafa, Muhamad},
  title = {Severe Cytokine Release Syndrome and Hemophagocytic Lymphohistiocytosis (HLH)-Like Syndrome Following Administration of Combined Brentuximab Vedotin and Nivolumab for Recurrent Classical Hodgkin Lymphoma: A Case Report},
  journal = {Journal of Blood Medicine},
  year = {2024},
  volume = {Volume 15},
  pages = {29--34},
  doi = {10.2147/jbm.s444004}
}
Kostenlos starten →